CD36 c.490_491delinsGC ;(p.K164A)

Variant ID: 7-80292366-AA-GC

NM_001001548.2(CD36):c.490_491delinsGC;(p.K164A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Role of CD36 in cancer progression, stemness, and targeting.

Frontiers In Cell And Developmental Biology
Guerrero-Rodríguez, Sandra L SL; Mata-Cruz, Cecilia C; Pérez-Tapia, Sonia M SM; Velasco-Velázquez, Marco A MA
Publication Date: 2022

Variant appearance in text: CD36: K164A
PubMed Link: 36568966
Variant Present in the following documents:
  • Main text
  • fcell-10-1079076.pdf
View BVdb publication page



The computational analyses, molecular dynamics of fatty-acid transport mechanism to the CD36 receptor.

Scientific Reports
Akachar, Jihane J; Etchebest, Catherine C; El Jaoudi, Rachid R; Ibrahimi, Azeddine A
Publication Date: 2021-12-01

Variant appearance in text: CD36: K164A
PubMed Link: 34853341
Variant Present in the following documents:
  • Main text
  • 41598_2021_Article_1373.pdf
View BVdb publication page



Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages.

The Journal Of Biological Chemistry
Kuda, Ondrej O; Pietka, Terri A TA; Demianova, Zuzana Z; Kudova, Eva E; Cvacka, Josef J; Kopecky, Jan J; Abumrad, Nada A NA
Publication Date: 2013-05-31

Variant appearance in text: CD36: K164A
PubMed Link: 23603908
Variant Present in the following documents:
  • Main text
View BVdb publication page